Spyre Therapeutics, Inc. (SYRE) Earnings
Spyre Therapeutics, Inc. is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $-0.70. SYRE has beaten EPS estimates in 3 of its last 9 reported quarters (average surprise -1.6% over the last four).
Next earnings
Aug 4, 2026in NaN days
EPS est $-0.70 · Revenue est —
Track record
Beat EPS in 3 of 9 quarters
Avg surprise -1.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 5, 2026 | $-0.66 | $-0.74 | -12.1% | — | — |
| Feb 19, 2026 | $-0.66 | $-0.70 | -6.1% | $90M | — |
| May 8, 2025 | $-0.76 | $-0.74 | +2.6% | — | — |
| Feb 27, 2025 | $-0.89 | $-0.81 | +9.0% | — | — |
| Nov 7, 2024 | $-0.80 | $-1.36 | -70.0% | — | — |
| May 9, 2024 | $-0.90 | $-1.20 | -33.3% | — | — |
| Feb 29, 2024 | $-0.48 | $-2.28 | -375.0% | $1M | +373.6% |
| Nov 9, 2023 | $-0.84 | $-9.34 | -1011.9% | — | — |
| Aug 11, 2023 | $-4.50 | $-1.66 | +63.1% | $688000 | +247.5% |
| Mar 31, 2021 | — | $-6.94 | — | — | — |
| Sep 30, 2020 | — | $-7.24 | — | — | — |
| Jun 30, 2020 | — | $-10.11 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.